Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Famotidine in the Clinical Recovery and Symptomatic Improvement of COVID-19 Patients.

NCT04504240 is registered in ClinicalTrials.gov with Chattogram General Hospital as lead sponsor.

NCT NCT04504240
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04504240 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Famotidine in the Clinical Recovery and Symptomatic Improvement of COVID-19 Patients.
Lead sponsor
Chattogram General Hospital
Phase
Phase 3
Overall status
Completed
Start date
August 1, 2020
Completion date
April 15, 2021
Enrollment
208 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

covid19